Read user reviews, compare products and contact manufacturers of drugs of abuse testing products, including forensic toxicology, blood chemistry analyzers and drugs of abuse immunoassays on SelectScience.
Point-Of-Care Diagnostics Market By Testing (Glucose Testing, Infectious Disease, Blood Gas Electrolyte, Cardiac Biomarker, Coagulation, Cholesterol, Pregnancy, Drugs Of Abuse, Urinalysis, Hematology), By Mode (Prescription-Based Testing, OTC-Based Testing), By End-Users (Hospitals And Clinics, Homecare Settings, Diagnostic Centers), Industry Analysis, Trends, And Forecast 2027
Increasing prevalence of infectious diseases across the world and changing healthcare practice environment is expected to drive the point-of-care diagnostics market growth
Point-of-Care Diagnostics Market is valued at USD 22688.6 Million in 2018 and expected to reach USD 46308.9 Million by 2025 with the CAGR of 10.73% over the forecast period.
Key Players for Point-of-Care Diagnostics Market Report–
Some major key players for global Point-of-Care Diagnostics market are Abbott Laboratories, Becton Dickinson & Co, Bio-Rad Laboratories, Inc, Trinity Biotech, Accubiotech, Quidel, Danaher, F. Hoffmann-La Roch